India · English
Dr Reddy's Gets Brazil Approval For Generic Ozempic Diabetes Drug
Indian pharmaceutical major Dr Reddy's Laboratories announced on Thursday that it has received regulatory approval in Brazil to market and sell a generic version of Novo Nordisk's widely used diabetes medicine Ozempic. Brazil's National Health Surveillance Agency (ANVISA) cleared the company's semaglutide injection for adults with type 2 diabetes whose blood sugar levels remain inadequately…
Read the full report at Free Press Journal →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.